Echocardiographic Predictors of Mortality in Women With Heart Failure With Reduced Ejection Fraction

Ingrid Josefine Lundorff1, Morten Sengeløv1, Peter Godsk Jørgensen1,2

  • 1Department of Cardiology, Herlev-Gentofte Hospital, University of Copenhagen. (I.J.L., M.S., P.G.J., S.P., D.M., N.E.B., T.F.-H., J.S.J., T.B.-S.).

Insights

In women with heart failure with reduced ejection fraction (EF), right ventricular function and left ventricular (LV) diastolic function are key predictors of mortality. For men with heart failure with reduced EF, LV systolic function is more critical.

Area of Science:

  • Cardiology
  • Echocardiography
  • Heart Failure Research

Background:

  • Global longitudinal strain predicts mortality in men with heart failure with reduced ejection fraction (EF), but this is not observed in women.
  • Sex-specific differences in cardiac function and mortality prediction in heart failure with reduced EF require further investigation.

Purpose of the Study:

  • To investigate sex-specific differences in cardiac function among patients with heart failure with reduced EF.
  • To identify echocardiographic predictors of all-cause mortality in women with heart failure with reduced EF.

Main Methods:

  • Retrieved echocardiographic examinations from 968 patients with heart failure with reduced EF (26.7% women).
  • Analyzed images offline, with all-cause mortality as the endpoint.
  • Performed multivariable adjustment to identify significant predictors of outcome.

Main Results:

  • Women exhibited higher left ventricular (LV) ejection fraction (EF), global longitudinal strain, and global circumferential strain compared to men.
  • Women had higher E/e', LV diastolic elastance, and lower e' than men.
  • Tricuspid annular plane systolic excursion and LV isovolumetric relaxation time predicted mortality in women; LVEF and global longitudinal strain predicted mortality in men.

Conclusions:

  • Tricuspid annular plane systolic excursion and LV isovolumetric relaxation time are significant predictors of mortality in women with heart failure with reduced EF.
  • Right ventricular function and LV diastolic function are paramount for predicting mortality in women.
  • LV systolic function is a more important predictor of mortality in men with heart failure with reduced EF.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
312